Prevention of deep vein thrombosis in total knee replacement - Current status of therapy in orthopedie and trauma departments in Germany;Thromboseprophylaxe in der knieendoprothetik - Stand der therapie an Deutschen orthopädisch-traumatologischen kliniken

Sportverletzung-Sportschaden

Volumn 20, Issue 3, 2006, Pages 149-152

  Luring C ^a   Oczipka, F ^a   Bathis H ^b   Grifka, J ^a   Tingart, M ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Deep vein thrombosis; National survey; Prevention of deep vein thrombosis; Total knee replacement

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN;

ARTICLE; CLINICAL PRACTICE; COMPRESSION STOCKING; EMERGENCY HEALTH SERVICE; GERMANY; HIP ARTHROPLASTY; ORTHOPEDICS; PREMEDICATION; QUESTIONNAIRE; STATISTICS; VEIN THROMBOSIS;

ARTHROPLASTY, REPLACEMENT, HIP; FIBRINOLYTIC AGENTS; GERMANY; HEPARIN; ORTHOPEDICS; PHYSICIAN'S PRACTICE PATTERNS; PREMEDICATION; QUESTIONNAIRES; STOCKINGS, COMPRESSION; TRAUMA CENTERS; VENOUS THROMBOSIS;

EID: 33750376098     PISSN: 09320555     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927000     Document Type: Article

References (26)

1. Anderson FA, Hirsh J. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 2003; 124 (6 Suppl): 349-356
2. AWMF-Online: Leitlinie zur Thromboembolie-Prophylaxe: AWMF-Leitlinien-Register, Nr. 037/003, http://www.uni-duesseldorf.de/AWMF/awmf- fr2.htm
3. Bäthis H, Tingart M, Perlick L et al. Stellenwert von Endoprothetik und Umstellungsosteotomien bei Gonarthrose. Ergebnisse einer Umfrage an Unfallchirurgischen und Orthopädischen Kliniken. Z Orthop Ihre Grenzgeb 2005; 143 (1): 19-24
4. Best A, Williams JS. Graded compression stockings in elective orthopaedic surgery. An assessment of the in vivo performance of commercially available stockings in patients having hip and knee arthroplasty. J Bone Joint Surg Br 2000; 82 (1): 116-118
5. Blanchard J, Meuwly JY, Leyvraz PF. Prevention of deep-vein thrombosis after knee replacement: randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg (Br) 1999; 81-B: 654-659
6. Brookenthal KR, Freedman KB. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty 2001; 16 (3): 293-300
7. Browse NL, Burnand KG, Irvine AT. Diseases of the veins. In: Arnold N (Hrsg). London: Second Edition: 1999
8. Cohen AT, Khushal A. Extended thromboprophylaxis following lower limb arthroplasty: what do the clinical trials mean? Haemostasis 2000; 2: 88-94
9. Colwell CW. Low molecular weight heparin prophylaxis in total knee arthroplasty: the answer. Clin Orthop 2001; 392: 245-248
10. Colwell CW. Managing thromboembolic risk in hip and knee arthroplasty: state of the art. Orthopedics 2003; 26 (2 Suppl): 231-236
11. Cordell-Smith JA, Williams SC. Lower limb arthroplasty complicated by deep venous thrombosis. Prevalence and subjective outcome. J Bone Joint Surg Br 2004; 86 (1): 99-101
12. Douketis JD, Eikelboom JW. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002; 162 (13): 1465-1471
13. Eikelboom JW, Quinlan DJ. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358 (9275): 9-15
14. Geerts WH, Heit JA, Clagett GP. Prevention of venous thromboembolism. Chest 2001; 119 (Suppl 1): 132-175
15. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the 7th ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (Suppl 3): 338S-400S
16. Gill SG, Mill SD, Joshi AB. Mortality following primary total knee arthroplasty. J Bone Joint Surg 2003; 85A: 432-435
17. Grifka J, Haas S, Hovy L et al. An update on thrombosis prophylaxis in orthopaedic and accident surgery. Orthopade 2004; 33 (7): 762-773
18. Haas S. Prevention, diagnosis and therapy of thromboses in orthopedic and trauma surgery. Orthopade 1997; 26: 1062-1074
19. Nicolaides AN, Breddin HK, Fareed J et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol 2001; 20 (1): 1-37
20. Patsch H, Blättler W. Leitlinien zur Thromboembolie-Prophylaxe. Phlebol 1996; 25: 261-266
21. Patsch H, Blättler W. Guidelines for thromboembolic prophylaxis: revised version. Phlebologie 2000; 29: 106-113
22. Schellong S, Hesselschwerdt HJ, Paar WD et al. Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery. Thromb Haemost 2005; 94 (3): 532-536
23. Schwenk W, Neudecker J, Raue W et al. Fast-track" rehabilitation after rectal cancer resection. Int J Colorectal Dis 2005; 9: 1-12
24. Silbersack Y, Taute BM, Hein W et al. Prevention of deep-vein thrombosis after total hip and knee replacement. Low-molecular-weight-heparin in combination with intermittent pneumatic compression. J Bone Joint Surg (Br) 2004; 86: 809-812
25. Verstraete M, Prentice CRM, Samama M. A European view on the North. American fifth consensus on antithrombotic therapy. Chest 2000; 117: 1755-1770
26. Warwick D, Harrison J, Glew D. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement: a prospective, randomised trial. J Bone Joint Surg (Am) 1998; 80: 1158-1166